SV

Street Verdict

Analyst Scorecard

A record of what Axis Securities Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Axis Securities recommends a 'BUY' on Abbott India Ltd. with a target price of Rs 31,420, implying a 10% upside from the current market price. The call is based on the company's 'Beyond the Pill' strategy, strong brand recognition, excellent product portfolio, and anticipated continued growth, with a valuation of 46.5x P/E for FY26E.”

Axis Securities Analysis’s track record (trackable calls only): 155 graded calls · 95% CI 34–49%

Abbott India Ltd.BullishCalled 29 Oct 2024
Verdict:PENDING

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹31,420, as stated.

Window: 12 months, the default when no time frame is stated.

Window still open: no verdict until a close reaches a level or the window ends.

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Tracking Abbott India Ltd. since this call

1-year tracking window
Read the original articleSee Axis Securities Analysis’s full track record